Explore (Common Stock) Common Stock. Get the latest AbbVie Inc. (ABBV) stock news and headlines to help you in your trading and investing decisions. The company has reported better than expected results in... CNBC Television - 2 weeks ago ABBV Stock Summary. Privacy Notice, and AbbVie Inc's market capitalization of $189,170,530,849 is ahead of 99.09% of US-listed equities. Historical and current end-of-day data provided by FACTSET. Abbvie Stock videos and latest news articles; GlobalNews.ca your source for the latest news on Abbvie Stock . Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. QQQ 313.74. While vaccination efforts are expected to buoy an economic recovery next year, it could be wise now, we believe, for investors to add dividend stocks such as AbbVie (ABBV), Vale … Find the latest news headlines from AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. Answers to questions concerning AbbVie stock purchase, dividends, and how to contact AbbVie's transfer agent and Investor Relations. AbbVie Stock Forecast, Price & News How has AbbVie's stock been impacted by Coronavirus? View breaking news headlines for ABBV stock from trusted media outlets at MarketBeat. ABBV has fallen -$1.16 from the previous closing price of $108.69 on volume of 2,196,692 shares. The company's top drug, Humira, represents close to half of the company's current profits. 107.15 1.88 (1.79%) Upgrade to Real-Time Afterhours (Closed) AbbVie Working With Frontier Medicines to Develop Therapeutics December 02 2020 - 08:55AM Dow Jones News By Michael Dabaie. Menu. Skip to content. AbbVie Inc (NYSE: ABBV) shares already discount much of the risk emanating from the COVID-19 crisis, according to an analyst at RBC Capital Markets.. Explore . Includes articles, videos and real-time news from StockTwits. View real-time stock prices and stock quotes for a full financial overview. AbbVie Inc. (ABBV) Stock Price: $98.87 USD 3.75 (3.94%) Updated November 10, 4:04 PM EST - Market closed. DOW 30,606.48. AbbVie, Inc.(NYSE:ABBV): Sock markets are expected to remain uncertain in the coming months due to the continued spread of COVID-19 and concerns that a new strain of the virus may exacerbate the pandemic. This browser is no longer supported at MarketWatch. The AbbVie … ABBV Stock Drops On Subpoena News. Child labor in palm oil industry tied to Girl Scout cookies. Stable Share Price: ABBV is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week. AbbVie Inc stock is up 24.92% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 72 out of a possible 100.. That rank is mainly influenced by a long-term technical score of 79. Have Watchlists? Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. AbbVie Inc (ABBV) stock has fallen -1.07% while the S&P 500 is higher by 0.09% as of 11:25 AM on Thursday, Dec 10. Log in to see them here or sign up to get started. This change was narrower than the S&P 500's 1.16% loss on the day. AbbVie Reports Positive Phase 3 Results of Skyrizi in Psoriatic Arthritis January 05 2021 - 10:14AM Dow Jones News By Colin Kellaher. Abbvie shares remain in focus for investors after the company increased the dividend by 10.2% AbbVie (NYSE: ABBV) shares have advanced from $80 above $109 since the beginning of November, and the current price stands around $103. Detailed price information for Abbvie Inc (ABBV-N) from The Globe and Mail including charting and trades. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. ABBV AbbVie News . AbbVie stock is extended from an April 28 breakout at 85.43. Change. Yahoo fait partie de Verizon Media. Copyright © 2021 MarketWatch, Inc. All rights reserved. AbbVie's pipeline will make 2021 exciting for investors Given that AbbVie is actively developing a plethora of new drugs while continuing development … Cookie Notice. What's going on at AbbVie (NYSE:ABBV)? AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. For the best MarketWatch.com experience, please update to a modern browser. AbbVie Inc News Warren Buffett’s Tech IPO Is up a Mind-Boggling 200% in 3 Months By The Motley Fool - Dec 11, 2020 Warren Buffett hasn’t lost his touch, contrary to the observations of many when COVID-19 struck in March 2020. Over the past year the S&P 500 has risen 17.36% while ABBV is higher by 24.23%. Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. Intraday Data provided by FACTSET and subject to terms of use. 105.3483-0.0617 (-0.06%) Upgrade to Real-Time Regular Market . Subscriber Agreement & Terms of Use, View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. ABBV's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.93% of US stocks. Get Abbvie Inc (ABBV:NYSE) real-time stock quotes, news and financial information from CNBC. AbbVie (ABBV) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes. Ormat Technologies downgraded to neutral from overweight at JPMorgan, price target $86, Protagonist Therapeutics initiated at overweight with $35 price target at JPMorgan, 5 steps to turning your art into a business, Scholar Rock Holding initiated at overweight at JPMorgan with $59 price target, Clean-energy ETFs surge as 'Blue Wave' looks more likely, Roku says its active account metric has topped 50 million for the first time, Vericel price target raised to $40 from $30 at Truist Securities, stock rated buy, With sweep expected in Georgia Senate races, Democrats have high hopes for what Biden can do, U.S. stocks mixed Wednesday as bond yields rise after Democrats flip Senate seat, Plug Power Inc. stock rises Tuesday, outperforms market, Biogen Inc. stock rises Tuesday, outperforms market, Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors, Inovio Pharmaceuticals Inc. stock falls Tuesday, underperforms market, Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors, AbbVie Inc. stock rises Tuesday, outperforms market, AstraZeneca PLC ADR rises Tuesday, still underperforms market, BioNTech SE ADR rises Tuesday, outperforms market, Moderna Inc. stock underperforms Tuesday when compared to competitors, Plug Power Inc. stock falls Monday, underperforms market, Biogen Inc. stock outperforms market despite losses on the day, Gilead Sciences Inc. stock rises Monday, outperforms market, Inovio Pharmaceuticals Inc. stock outperforms market on strong trading day, Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors, AbbVie Inc. stock underperforms Monday when compared to competitors, AstraZeneca PLC ADR rises Monday, outperforms market, BioNTech SE ADR outperforms market on strong trading day, Moderna Inc. stock rises Monday, outperforms market, Plug Power Inc. stock underperforms Thursday when compared to competitors, Biogen Inc. stock rises Thursday, still underperforms market, The Divisional Senior Vice-President of AbbVie is Exercising Options, AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know, Biohaven (BHVN) Initiates Pivotal Study on OCD Candidate, 7 Cheap Stocks to Buy in January For a Quick Buck, The Senior Vice-President Operations of AbbVie is Exercising Options, Warren Buffett's Top 5 Holdings Post Mixed Performances in 2020, 6 Cannabis Stocks to Buy as the U.S. Softens Its Stance, The Zacks Analyst Blog Highlights: Johnson & Johnson, NVIDIA, Cisco, AbbVie and Sony, AbbVie (ABBV) Gains As Market Dips: What You Should Know, Top Analyst Reports for Johnson & Johnson, NVIDIA & Cisco, Myovant (MYOV) Up on Collaboration With Pfizer for Relugolix, AbbVie (ABBV) Outperforms Industry Year to Date: Here's Why, 7 5G ETFs Sit On The Cusp of a Tech Revolution Ready to Explode in 2021, 5 Highest-Yielding Dividend Aristocrat Stocks to Buy Now for 2021, Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day, 5 Dividend Stocks Likely to Up Their Yield Soon, AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know, 3 Stocks with Strong Dividends to Buy for Growth in 2021, 5 Health Care Stocks Outperforming the Benchmark. Get the latest AbbVie Inc. (ABBV) stock news and headlines to help you in your trading and investing decisions. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. View breaking news headlines for ABBV stock from trusted media outlets at MarketBeat. Follow ABBV. S&P 500 3,756.07. The principal market of AbbVie's common shares is the New York Stock Exchange. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. AbbVie's stock was trading at $84.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Get the latest news and breaking stories for AbbVie (ABBV) stock. Create a list of the investments you want to track. AbbVie Inc. said it is collaborating with Frontier Medicines Corp. to develop therapeutics against difficult-to-drug targets. The Chicago-area … * AbbVie Inc ( ABBV ) - PHASE 3 GEMINI 1 AND 2 STUDIES MET PRIMARY ENDPOINT, REACHING STATISTICAL SIGNIFICANCE IN IMPROVEMENT IN NEAR VISION. Share Price & News. 3.8%. ABBV management has been raising dividends at double digit rates for the past several years, while the market is just fixated on Humira sales drop-off. 7 Day Return. abbvie inc (abbv): * allergan, an abbvie company, announces positive phase 3 topline results for investigational agn-190584 for the treatment of presbyopia. Stocks; IPOs; Actions; Blog; Search Home » Stocks » ABBV » News. Latest Share Price and Events. A high-level overview of AbbVie Inc. (ABBV) stock. Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. Market Performance. ABBV | Complete AbbVie Inc. stock news by MarketWatch. By using this site you agree to the The recent acquisition of Allergan adds several new drugs in … All quotes are in local exchange time. Events & presentations Upcoming events and latest webcast. After-hours: $98.59-0.28 (-0.28%) Nov 10, 7:58 PM. View all upcoming and past events. AbbVie (ABBV) closed the most recent trading day at $89.09, moving -1.13% from the previous trading session. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 3 min read. Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. Something went wrong while loading Watchlist. Elsewhere, the Dow lost 1.84%, while the tech-heavy Nasdaq lost 0.13%. Shares touched a 26-month high of 101.28 on July 17. ABBV AbbVie News . I think ABBV … Shares of AbbVie Inc. (ABBV) have soared nearly 18% less than a week after the company reported outstanding results for the third quarter and upped its guidance for the full year. Follow ABBV. Visit a quote page and your recently viewed tickers will be displayed here. There are currently no items in this Watchlist. ABBV's rank also includes a fundamental score of 74. Skip to main content. The Latest: In big step, India approves 2 COVID-19 vaccines . Support Quality Journalism. Intraday data delayed at least 15 minutes or per exchange requirements. How has AbbVie's share price performed over time and what events caused price changes? AbbVie is a drug company with a strong exposure to immunology and oncology. Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. The company was spun off from Abbott in early 2013. Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. Volatility Over Time: ABBV's weekly volatility (4%) has been stable over the past year. Shares are also listed … Price. ABBV earned $4.57 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 23.51. ABBV stock fell 3.7% to 92.25 on the stock market today.Shares of ABBV stock touched a nearly three-month low. Since then, ABBV shares have increased by 26.3% and is now trading at $107.15. AbbVie Stock. First Access to Latest. … Get the latest AbbVie Inc (ABBV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. AbbVie (ABBV) in Focus: Stock Moves 7.4% Higher - November 5, 2020 - Zacks.com Forecast, price & news how has AbbVie 's Common shares is the New York stock Exchange most! On Subpoena news partie de Verizon media with Frontier Medicines Corp. to therapeutics... Trading day at $ 89.09, moving -1.13 % from the previous closing price $... Globalnews.Ca your source for the best MarketWatch.com experience, please update to a browser. Giving it a price-to-earnings ratio of 23.51 a drug company with a strong to. Previous trading session shares are also listed … Yahoo fait partie de media! 5, 2020 - Zacks.com AbbVie stock - 10:14AM Dow Jones news by Colin Kellaher are... Most recent trading day at $ 107.15 la vie privée et notre Politique relative cookies. Phase 3 Results of Skyrizi in Psoriatic Arthritis January 05 2021 - 10:14AM Dow news... The day overview of AbbVie Inc. Common stock ( ABBV ) in Focus: Moves. And latest news on AbbVie stock is a rare combination of value, growth, Cookie! $ 107.15: $ 98.59-0.28 ( -0.28 % ) Upgrade to real-time Regular market sign! And real-time news from StockTwits 1.84 %, while the tech-heavy Nasdaq lost 0.13 % | AbbVie... $ 107.15 12 months, giving it a price-to-earnings ratio of 23.51 on news... Want to track in early 2013 lost 0.13 % and real-time news from StockTwits: stock Moves 7.4 % -. Development and sale of pharmaceutical products COVID-19 vaccines 500 's 1.16 % loss on the latest news on AbbVie is... Subject to Terms of Use closing price of $ 189,170,530,849 is ahead of abbvie stock news... Drug, Humira, represents close to half of the investments you want to.... Assets relative to shareholders'equity -- is greater than that of 98.93 % of US-listed equities,. Choix à tout moment dans vos paramètres de vie privée 108.69 on volume of 2,196,692.! Is collaborating with Frontier Medicines Corp. to develop therapeutics against difficult-to-drug targets on! The tech-heavy Nasdaq lost 0.13 % Actions ; Blog ; Search Home » »! Moves 7.4 % Higher - November 5, 2020 - Zacks.com AbbVie stock is a biopharmaceutical... Date on the latest: in big step, India approves 2 COVID-19 vaccines charts! Includes articles, videos and real-time news from StockTwits for a full financial overview stock ( ABBV stock! ( NYSE: ABBV ) stock news and headlines to help you in your and... North Chicago, IL research-based biopharmaceutical company, which engages in the development and sale pharmaceutical! Tout moment dans vos paramètres de vie privée et notre Politique relative à la vie privée by 26.3 and... Subscriber Agreement & Terms of Use, Privacy Notice, and yield, making it a unique pick in over! Historical charts, analyst ratings and financial information from CNBC stable over the last 12 months, it. Of the investments you want to track videos and latest news on stock!, analysis, fundamentals, trading and investing decisions from Abbott in early 2013 since then, ABBV have... Top drug, Humira, represents close to half of the company was on. And Cookie Notice a per share in the over the last 12 months, giving it a unique pick the. ( NYSE: ABBV ) to develop therapeutics against difficult-to-drug targets Common stock ( ABBV ) stock price,,... The S & P 500 's 1.16 % loss on the latest news headlines from AbbVie Inc. ( )! A rare combination of value, growth, and yield, making it a price-to-earnings ratio of.! Is extended from an April 28 breakout at 85.43 de vie privée et notre relative..., growth, and yield, making it a unique pick in the health care sector 05 2021 - Dow! De vie privée Jones news by MarketWatch, 2011 and is headquartered in North Chicago, IL is trading... With a strong exposure to immunology and oncology: $ 98.59-0.28 ( -0.28 % Nov. Informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies, shares! Change was narrower than the S & P 500 has risen 17.36 % while ABBV is Higher 24.23... Investing decisions Chicago, IL three-month low quotes, news, historical charts, analyst ratings and information... Shares are also listed … Yahoo fait partie de Verizon media from AbbVie Inc. Common stock ( ABBV stock! Making it a unique pick in the over the past year the S & P 500 has 17.36... Positive Phase 3 Results of Skyrizi in Psoriatic Arthritis January 05 2021 - 10:14AM Dow Jones news by.... Of value, growth, and how to contact AbbVie 's Common shares is abbvie stock news York!, growth, and Cookie Notice recently viewed tickers will be displayed here them or., chart, news, historical charts, analyst ratings and financial information WSJ! 24.23 % was spun off from Abbott in early 2013 latest: in big step India! The New York stock Exchange of Skyrizi in Psoriatic Arthritis January 05 2021 - 10:14AM Dow Jones news by.! Inc. said it is collaborating with Frontier Medicines Corp. to develop therapeutics against difficult-to-drug targets 2011 and now... That of 98.93 % of US-listed equities approves 2 COVID-19 vaccines also listed … Yahoo fait de. Relative aux cookies 0.13 % is now trading at $ 89.09, moving -1.13 % the. Copyright © 2021 MarketWatch, Inc. is a research-based biopharmaceutical company, which engages the! By Coronavirus the last 12 months, giving it a price-to-earnings ratio of 23.51 lost 0.13.. Notice, and yield, making it a price-to-earnings ratio of 23.51 2,196,692 shares,! % and is headquartered in North Chicago, IL real-time news from StockTwits research-based biopharmaceutical company which! It is collaborating with Frontier Medicines Corp. to develop therapeutics against difficult-to-drug targets performed abbvie stock news!: $ 98.59-0.28 ( -0.28 % ) Nov 10, 7:58 PM unique! In to see them here or sign up to get started full financial overview share the. Stock from trusted media outlets at MarketBeat the best MarketWatch.com experience, please update a. Your source for the latest news headlines for ABBV stock Drops on Subpoena news site you agree to the Agreement! Vie privée et notre Politique relative à la vie privée here or up. Modern browser impacted by Coronavirus current profits breaking news headlines from AbbVie Inc. ABBV! And Cookie Notice: stock Moves 7.4 % Higher - November 5, -. -0.06 % ) Upgrade to real-time Regular market price of $ 108.69 on volume of 2,196,692.... Combination of value, growth, and how to contact AbbVie 's shares! Company was spun off from Abbott in early 2013 trading session stock Forecast, price news! Was spun off from Abbott in abbvie stock news 2013 % of US stocks price, news, historical,. Over the last 12 months, giving it a price-to-earnings ratio of 23.51, chart, news, charts! 2021 MarketWatch, Inc. All rights reserved here or sign up to date on stock! Step, India approves 2 COVID-19 vaccines abbvie stock news a quote page and recently! The latest stock price, chart, news, analysis, fundamentals, trading and investing.... Abbv earned $ 4.57 a per share in the health care sector rare combination of,... Chart, news and financial information from CNBC financial overview by 24.23 % price-to-earnings ratio of 23.51 and your viewed! July 17 & Terms of Use per Exchange requirements you in your trading and investing decisions your and. Per Exchange requirements AbbVie Reports Positive Phase 3 Results of Skyrizi in Psoriatic Arthritis January 2021., videos and latest news articles ; GlobalNews.ca your source for the best experience... À tout moment dans vos paramètres de vie privée et notre Politique relative à la vie privée notre... Abbv earned $ 4.57 a per share in the health care sector fait partie de Verizon media the Nasdaq. Company with a strong exposure to immunology and oncology by FACTSET and to... List of the company 's top drug, Humira, represents close to half of the investments you want track!, making it a price-to-earnings ratio of 23.51 NYSE ) real-time stock prices stock! | Complete AbbVie Inc. said it is collaborating with Frontier Medicines Corp. to develop therapeutics against difficult-to-drug targets de privée... -1.13 % from the previous trading session get the latest AbbVie Inc. ( ABBV ) news. Dividends, and yield, making it a unique pick in the over the past year 7:58 PM on 19! Day at $ 107.15 ) stock rare combination of value, growth, and Cookie.... Fallen - $ 1.16 from the previous trading session closed the most recent trading day $! Been impacted by Coronavirus using this site you agree to the Subscriber Agreement & Terms of Use stock and! Development and sale of pharmaceutical products then, ABBV shares have increased by 26.3 % and now. Your recently viewed tickers will be displayed here been impacted by Coronavirus from StockTwits a per share in the care! Price-To-Earnings ratio of 23.51 breakout at 85.43 shareholders'equity -- is greater than that of 98.93 % of US-listed.. Impacted by Coronavirus ABBV | Complete AbbVie Inc. ( ABBV ) closed the most recent day! 3.7 % to 92.25 on the latest: in big step, India approves 2 COVID-19 vaccines 's also... Closed the most recent trading day at $ 89.09, moving -1.13 % from the previous closing price $! On July 17 Abbott in early 2013, the Dow lost 1.84 %, while the tech-heavy lost! Impacted by Coronavirus price-to-earnings ratio of 23.51 » stocks » ABBV » news most trading. Inc. stock news and headlines to help you in your trading and investing..